Safety of Recombinant HIV Vaccines in HIV Infected Young Adults on Stable Therapy
Public ClinicalTrials.gov record NCT00107549. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Phase I, Open-Label Study to Evaluate the Safety and Tolerability of Recombinant HIV-1 Vaccines in HIV-1 Infected Young Adults With Control of HIV-1 Replication and on Stable Highly Active Antiretroviral Therapy (HAART)
Study identification
- NCT ID
- NCT00107549
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 1
- Lead sponsor
- National Institute of Allergy and Infectious Diseases (NIAID)
- NIH
- Enrollment
- 20 participants
Conditions and interventions
Conditions
Interventions
- rMVA-HIV (env/gag [TBC-M358] + tat/rev/nef-RT [TBC-M335)]) Biological
- rFPV-HIV (env/gag [TBC-F357] + tat/rev/nef-RT [TBC-F349]) Biological
Biological
Eligibility (public fields only)
- Age range
- 18 Years to 24 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Not listed
- Primary completion
- Not listed
- Completion
- Jan 31, 2009
- Last update posted
- Oct 31, 2021
Ends 2009
United States locations
- U.S. sites
- 8
- U.S. states
- 7
- U.S. cities
- 7
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Children's Hospital Los Angeles NICHD CRS | Los Angeles | California | 90027 | — |
| Usc La Nichd Crs | Los Angeles | California | 90033 | — |
| Univ. of Colorado Denver NICHD CRS | Aurora | Colorado | 80218-1088 | — |
| Chicago Children's CRS | Chicago | Illinois | 60614 | — |
| Univ. of Maryland Baltimore NICHD CRS | Baltimore | Maryland | — | — |
| Columbia IMPAACT CRS | New York | New York | — | — |
| DUMC Ped. CRS | Durham | North Carolina | — | — |
| St. Jude/UTHSC CRS | Memphis | Tennessee | 38105-2794 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 1 non-U.S. site.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT00107549, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Oct 31, 2021 · Synced Jul 21, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT00107549 live on ClinicalTrials.gov.